Karen Nora McCarthy

Dr. Karen Nora McCarthy

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2018 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
KMKaren Nora McCarthy
Karen Nora McCarthy
AHA Hawke
A Hawke
EDEugene Dempsey
Eugene Dempsey

23 May 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
AKAlanna M. Kelly
Alanna M. Kelly
KMKaren Nora McCarthy
Karen Nora McCarthy
TCTracey J. Claxton
Tracey J. Claxton
SCSimon R. Carlile
Simon R. Carlile
EOEoin C. O’BRien
Eoin C. O’BRien
Rachel McLoughlinRachel McLoughlin
Rachel McLoughlin
Staphylococcus aureus is a major human pathogen. An effective anti– S . aureus vaccine remains elusive as the correlates of protection are ill-defined. Targeting specific T cell populations is an important strategy for improving anti– S . aureus vaccine efficacy. Potential bottlenecks that remain are S . aureus –induced immunosuppression and the impact this might have on vaccine-induced immunity. S . aureus induces IL-10, which impedes effector T cell responses, facilitating persistence during both colonization and infection. Thus, it was hypothesized that transient targeting of IL-10 might represent an innovative way to improve vaccine efficacy. In this study, IL-10 expression was elevated in the nares of persistent carriers of S . aureus , and this was associated with reduced systemic S . aureus –specific Th1 responses. This suggests that systemic responses are remodeled because of commensal exposure to S . aureus , which negatively implicates vaccine function. To provide proof of concept that targeting immunosuppressive responses during immunization may be a useful approach to improve vaccine efficacy, we immunized mice with T cell–activating vaccines in combination with IL-10–neutralizing antibodies. Blocking IL-10 during vaccination enhanced effector T cell responses and improved bacterial clearance during subsequent systemic and subcutaneous infection. Taken together, these results reveal a potentially novel strategy for improving anti– S . aureus vaccine efficacy.

28 September 2018 in Archives of Disease in Childhood - Fetal and Neonatal Edition
Verified
Journal Article
Closed access
PDF file
KMKaren Nora McCarthy
Karen Nora McCarthy
NRNiamh C Ryan
Niamh C Ryan
DODarragh T O’sHea
Darragh T O’sHea
KDKieran Doran
Kieran Doran
RGRichard Greene
Richard Greene
EDEugene Dempsey
Eugene Dempsey
Background Neonatal research, particularly neonatal emergency research is a challenging area, notably in relation to obtaining valid prospective informed consent. The aim of this study is to determine parental perceptions of the consent process involved in performing research in newborn care, to explore methods used to obtain consent and their acceptability to parents. Methods A parental questionnaire was developed that examined attitudes towards research and hypothetical research studies, in which the acceptability of various methods of consent was examined (informed, waived, deferred). These research scenarios were of varying time sensitivity and perceived risk level. The study setting was an Irish maternity hospital. Results There were 600 responses to the questionnaire. In 93% of cases, parents felt that their involvement in the consent process was essential. In emergency situations, 52% felt full prospective informed consent was necessary; however, almost 28% of parents would feel pressure to consent. Most (75%) parents would prefer to be approached to discuss neonatal research studies antenatally, irrespective of study type and 40% of parents felt that neonates involved in research studies received overall better care. Acceptability of deferred consent was greater than waived, and was highest for the more emergency-based scenarios presented. Discussion Parents feel that they should play a central role in research involving their children. There were differences in the acceptability of various consent methods with strongest agreement for informed consent and lowest agreement for waived consent. Parents were more willing to accede to deferred consent in the cardiopulmonary resuscitation scenario study. These findings provide useful insights to consent strategies in future newborn research studies.

3 December 2020 in Archives of Disease in Childhood - Fetal and Neonatal Edition
Verified
Journal Article
Closed access
PDF file
KMKaren Nora McCarthy
Karen Nora McCarthy
APAndrea Pavel
Andrea Pavel
AGAisling Garvey
Aisling Garvey
AHAna-Louise Hawke
Ana-Louise Hawke
CLCriona Levins
Criona Levins
EDEugene M Dempsey
Eugene M Dempsey
Background Non-invasive cardiac output monitoring (NICOM) provides continuous estimation of cardiac output. This has potential for use in the delivery suite in the management of acutely depressed term infants. This study aims to measure cardiac output in term infants at delivery and in the first hours of life. Methods Parents of term infants due to be born by elective caesarean section or vaginal delivery at Cork University Maternity Hospital, Ireland were approached in the antenatal period to participate. Cardiac output was measured using a CHEETAH NICOM device, which uses electrical bioreactance technology, at birth and at 2 hours of life. Results Forty-nine newborns were included. The median gestational age was 39 (IQR: 39–40) weeks and the median birth weight was 3.50 (IQR: 3.14–3.91) kg. Cardiac output measurements were obtained at a median of 8 (IQR: 5–12) min of life. The mean (SD) cardiac output was 101 (24) mL/kg/min in the delivery room and 89 (22) mL/kg/min at 2 hours of life. There was a statistically significant decrease in cardiac output from birth to 2 hours of life (difference in mean (95% CI): 13.5 (9.2 to 17.9) mL/kg/min, p<0.001, n=47). There were no adverse effects associated with NICOM. Discussion This technique is feasible and safe in the delivery room. Mean cardiac output measures using NICOM are lower than those found in studies which used echocardiography to determine cardiac output at birth.

9 January 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
KMKaren Nora McCarthy
Karen Nora McCarthy
KTKara Tedford
Kara Tedford
EKEimear Kitt
Eimear Kitt
The Emergency Department (ED) represents an ideal location for antimicrobial stewardship (AMS) intervention, given the large volume of antibiotics seen prescribed to a wide variety of patients. This is particularly true in paediatrics, where most infectious presentations are viral in nature. A recent European Society of Clinical Microbiology and Infectious Diseases (ESCMID) position paper addressed four key areas affecting adult ED. This included: (1) the utility of biomarkers or rapid pathogen tests, (2) the impact of blood cultures on antibiotic prescribing, (3) the effect of watchful waiting on clinical outcomes, and (4) the potential for structured follow-up programmes within the ED to impact prescribing. Comparatively, the paediatric ED remains underrepresented in the literature with regard to AMS interventions. In this review article, we review the evidence surrounding the above four key areas as they relate to the paediatric population.